| Heading: |
Cancer: Drugs |
| Question ID: |
1761254 |
| UIN: |
28209 |
| House: |
Commons |
| Date tabled: |
2025-02-03 |
| Asking Member ID: |
5207 |
| Asking Member display name: |
Clive Jones
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Clive Jones
|
| Member interest: |
true |
| Question text: |
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 13 January 2025 to Question 21831 on Cancer: Drugs, if his Department will make an assessment of the potential implications for his policies of the findings on page 21 of |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-02-11 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Government wants National Health Service patients to benefit from effective NHS treatments at a price that is fair to the NHS and the taxpayer. It is important that we have a system in place for making evidence-based decisions on whether new medicines... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |